PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 223 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $378,000 | – | 14,102 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 170,129 | $3,321,000 | 9.18% |
| CADIAN CAPITAL MANAGEMENT, LP | 6,462,605 | $126,150,000 | 5.87% |
| Fernwood Investment Management, LLC | 340,263 | $6,642,000 | 4.28% |
| Tamarack Advisers, LP | 400,000 | $7,808,000 | 3.18% |
| Grace Capital | 279,209 | $5,456,000 | 2.53% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,582,129 | $30,883,000 | 2.37% |
| Foresite Capital Management IV, LLC | 250,000 | $4,880,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 823,607 | $16,077,000 | 2.18% |
| HARVEY CAPITAL MANAGEMENT INC | 164,672 | $3,214,000 | 1.71% |
| WISCONSIN CAPITAL MANAGEMENT LLC | 68,549 | $1,338,000 | 1.42% |